A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 6935
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : s.c
Long Form : subcutaneous
No. Year Title Co-occurring Abbreviation
2022 Administration routes for SSTR- / PSMA- and FAP-directed theranostic radioligands in mice. FAP, i.p, i.v, p.i, PSMA, SSTR
2022 Effects of subcutaneous injectıon after coolant spray on pain, hematoma, and ecchymosıs in three different regions. LMWH
2022 Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era. COVID-19, HCPs, IBD
2021 A 28-Day Toxicity Study of Tenofovir Alafenamide Hemifumarate by Subcutaneous Infusion in Rats and Dogs. HF, HIV, PrEP, TAF, TFV, TFV-DP
2021 A Clinical Rationale for Assessing the Impact of Childhood Sexual Abuse on Adjunctive Subcutaneous Esketamine for Treatment-Resistant Depression. CSA, DAG, TRD
2021 A comparative pharmacokinetic study of a novel sustained release danofloxacin formulation and the conventional product in rabbits. AUC, AUMC, DANO, MRT, PK, tmax
2021 A novel aqueous dimethyl trisulfide formulation is effective at low doses against cyanide toxicity in non-anesthetized mice and rats. CN, DMTS, HCN, IM
2021 A novel oral formulation of BIO 300 confers prophylactic radioprotection from acute radiation syndrome in mice. DEARE, H-ARS, MCM, OP
2021 A Phase 1 first-in-human study of the safety, tolerability, and pharmacokinetics of the ROBO2 fusion protein PF-06730512 in healthy participants. ADA, FSGS, MAD, SAD, TEAEs
10  2021 A phase I, first-in-human, randomized dose-escalation study of anti-activated factor XII monoclonal antibody garadacimab. COVID-19, FXII, i.v, TEAE
11  2021 A population-adjusted indirect comparison of cardiovascular benefits of once-weekly subcutaneous semaglutide and dulaglutide in the treatment of patients with type 2 diabetes, with or without established cardiovascular disease. CI, CV, CVD, CVOTs, HRs, MACE, MAIC
12  2021 A Scoping Review of Alternative Anticoagulation Strategies for Hemodialysis Patients with a Mechanical Heart Valve. CUA, ESRD, LMWH, VKA
13  2021 Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis. ABA, pJIA
14  2021 Acetylsalicylic Acid Compared with Enoxaparin for the Prevention of Thrombosis and Mechanical Ventilation in COVID-19 Patients: A Retrospective Cohort Study. OR
15  2021 Acute shock efficacy of the subcutaneous implantable cardioverter-defibrillator according to the implantation technique. DE, IM, S-ICD
16  2021 Adverse effects of subcutaneous vs intravenous hydration in older adults: An assessor-blinded randomised controlled trial (RCT). RCT
17  2021 Agonistic analog of growth hormone-releasing hormone promotes neurofunctional recovery and neural regeneration in ischemic stroke. GHRH, tMCAO
18  2021 All-trans retinoic acid alters the expression of adipogenic genes during the differentiation of bovine intramuscular and subcutaneous adipocytes. ATRA, GLUT4, IM, PPAR, RAR, RPS9, SCD, Smad3
19  2021 Alpha-Fetoprotein- and CD40Ligand-Expressing Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma. AFP, CD40L, DC, HCC, i.t, i.t
20  2021 Analysis of N15-rat growth hormone after incubation with rat subcutaneous tissue and immune cells using ultra-pressure chromatography-mass spectrometry. cPBMCs, hGH, rGH, ROS, TPs
21  2021 Analysis of the Immunogenicity from Abatacept-Treated Pediatric Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Findings From Two Phase III Clinical Trials. MTX, pJIA
22  2021 Analysis of the tumor microenvironment and anti-tumor efficacy of subcutaneous vs systemic delivery of the bifunctional agent bintrafusp alfa. anti-PDL1, i.v, M-MDSCs, mAbs, TME
23  2021 Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for people with asthma. ED, ICS, LABA, LAMA, OCS, Th2
24  2021 Antimicrobial Efficacy of Aqueous Ozone and Ozone-Lactic Acid Blend on Salmonella-Contaminated Chicken Drumsticks Using Multiple Sequential Soaking and Spraying Approaches. CFU, CI, O3-LA, RAC
25  2021 APB-F1, a long-acting feline granulocyte colony-stimulating factor fusion protein, created by exploiting FL335, a chimeric Fab specific for feline serum albumin. ADA, ANC, CHO, fG-CSF, FSA, hG-CSF, PD, PK, SAFA, WBC
26  2021 Apelin and Vasopressin: The Yin and Yang of Water Balance. ---
27  2021 Assessing the cost and quality-of-life impact of on-demand-only medications for adults with hereditary angioedema. HAE, QoL
28  2021 Association of a vaccine adjuvant with endogenous HDL increases lymph uptake and dendritic cell activation. CTL, DCs, HDLs, OVA
29  2021 Benefits of Switch from Oral to Subcutaneous Route on Adherence to Methotrexate in Patients with Rheumatoid Arthritis in Real Life Setting. LDA, MTX, RA
30  2021 Bictegravir Plus Tenofovir Alafenamide Nanoformulation as a Long-Acting Pre-Exposure Prophylaxis Regimen: Application of Modeling to Design Non-Human Primate Pharmacokinetic Experiments. BIC, MBPK, NHP, TAF
31  2021 Bioavailability study of Enoxaparin Sodium Chemi (80 mg/0.8 mL) and Clexane (80mg/0.8mL) subcutaneous injection in healthy adults. CI, TEAE
32  2021 Bioequivalence of intramuscular and subcutaneous peginterferon beta-1a: results of a phase I, open-label crossover study in healthy volunteers. AUCinf, CI, IM, ISRs, LS, PD, PK, RMS, RRMS
33  2021 Bisphosphonate application and volumetric effects on MRONJ lesions. MRONJ
34  2021 BMP7 Increases UCP1-Dependent and Independent Thermogenesis with a Unique Gene Expression Program in Human Neck Area Derived Adipocytes. BMP-7, DN, UCP1
35  2021 Budget Impact Analysis of the Introduction of Subcutaneous Infliximab (CT-P13 SC) for the Treatment of Rheumatoid Arthritis in the United Kingdom. RA
36  2021 Cache Domain Containing 1 Is a Novel Marker of Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis. CACHD1, DM, HCAs, HFD, STZ
37  2021 Caffeine as a Viscosity Reducer for Highly Concentrated Monoclonal Antibody Solutions. mAb
38  2021 Can We Decrease Epicardial and Pericardial Fat in Patients With Diabetes? AF, AT, CV, DM, EAT, HF, PAT, T2DM
39  2021 Case Report: Use of Subcutaneous Midazolam During an Episode of Catatonia. BFCRS, BZD, PKD
40  2021 Catfish Epidermal Preparation Accelerates Healing of Damaged Nerve in a Sciatic Nerve Crush Injury Rat Model. i.p
41  2021 Cebranopadol, a novel first-in-class drug candidate: Method validation and first exploratory pharmacokinetic study in rabbits. ---
42  2021 Cell-permeable transgelin-2 as a potent therapeutic for dendritic cell-based cancer immunotherapy. BMDCs, DC, i.v, LNs
43  2021 Central and peripheral emetic loci contribute to vomiting evoked by the Akt inhibitor MK-2206 in the least shrew model of emesis. DVC, GSK-3
44  2021 Characterization and differentiation potential of mesenchymal stem cells isolated from multiple canine adipose tissue sources. IPFP, MSCs, OM, PR
45  2021 Characterization of a xenograft model for anti-CD19 CAR T cell studies. CAR, i.p
46  2021 Characterization of beta-adrenergic receptors in bovine intramuscular and subcutaneous adipose tissue: comparison of lubabegron fumarate with beta-adrenergic receptor agonists and antagonists. DOB, IM, ISO, LUB, NEFA, RAC, SAL, ZIL
47  2021 Chemogenetic activation of endogenous arginine vasopressin exerts anorexigenic effects via central nesfatin-1/NucB2 pathway. AVP
48  2021 Chronic Exposure to Morphine Leads to a Reduced Affective Pain Response in the Presence of Hyperalgesia in an Animal Model of Empathy. CPA, EPM, OFT
49  2021 Combination of pasireotide and octreotide: effects on GH and IGF-I secretion and glucose metabolism in healthy volunteers. GH, IGF-I, LAR
50  2021 Comparable Pharmacokinetics, Safety, and Tolerability of Etrolizumab Administered by Prefilled Syringe or Autoinjector in a Randomized Trial in Healthy Volunteers. AI, CI, GMRs, PFS-NSD
51  2021 Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti-tumor necrosis factor experienced Crohn's disease patients: A propensity-score matched cohort analysis. CD, HD, IQR, SD, TNF
52  2021 Comparative efficacy of subcutaneous (CT-P13) and intravenous infliximab in adult patients with rheumatoid arthritis: a network meta-regression of individual patient data from two randomised trials. ACR, CDAI, CI, HAQ-DI, RA, SDAI
53  2021 Comparison between three dosages of intramuscular alfaxalone and a ketamine-dexmedetomidine-midazolam-tramadol combination in golden-headed lion tamarins (Leontopithecus chrysomelas). GHLTs, IM, KDMT
54  2021 Comparison of equivalent fractional vaccine doses delivered by intradermal and intramuscular or subcutaneous routes: A systematic review. ID, IM
55  2021 Comparison of Naturally Occurring vs. Experimental Infection of Staphylococcus aureus Septicemia in Laying Hens in Two Different Age Groups. SA
56  2021 Comparison of Pharmacokinetic, Pharmacodynamic and Tolerability Profiles of CKD-11101, Darbepoetin Alfa (NESP) Biosimilar, to Those of NESP After a Single Subcutaneous or Intravenous Administration to Healthy Subjects. CIs, GMR, PD, PK
57  2021 Comparison of the immune response following subcutaneous versus intranasal modified-live virus booster vaccination against bovine respiratory disease in pre-weaning beef calves that had received primary vaccination by the intranasal route. i.n, MLV, SNA
58  2021 Comprehensive evaluation of microneedle-based intradermal adalimumab delivery vs. subcutaneous administration: results of a randomized controlled clinical trial. ID
59  2021 Continuous intravenous anakinra for treating severe secondary haemophagocytic lymphohistiocytosis/macrophage activation syndrome in critically ill children. IL-1, MAS, sHLH
60  2021 Cost-effectiveness of intravenous vedolizumab vs subcutaneous adalimumab for moderately to severely active ulcerative colitis. ADR, DDW, ECCO, UC
61  2021 CRTC3 Regulates the Lipid Metabolism and Adipogenic Differentiation of Porcine Intramuscular and Subcutaneous Adipocytes by Activating the Calcium Pathway. cAMP, CRTC3, GP, IM
62  2021 CTRP12 Alleviates Isoproterenol Induced Cardiac Fibrosis via Inhibiting the Activation of P38 Pathway. TNF
63  2021 Dasiglucagon, a next-generation ready-to-use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: Results of a phase 3, randomized controlled trial. PG
64  2021 Delta9-Tetrahydrocannabinol discrimination: Effects of route of administration in rats. i.p, ROA, THC
65  2021 Depth of tumor implantation affects response to in situ vaccination in a syngeneic murine melanoma model. ID, ISV
66  2021 Development and testing of the Satisfaction Questionnaire with Intravenous or Subcutaneous Hemophilia Injection and results from the Phase 3 HAVEN 3 study of emicizumab prophylaxis in persons with haemophilia A without FVIII inhibitors. CI, FVIII, PwHA, SQ-ISHI
67  2021 Different protective efficacies of a novel antigen-specific DNA vaccine encoding chicken type Ⅱ collagen via intramuscular, subcutaneous, and intravenous vaccination against experimental rheumatoid arthritis. anti-CCP, CIA, IM, RA, RF
68  2021 Dispersive effects and focused biodistribution of recombinant human hyaluronidase PH20: A locally acting and transiently active permeation enhancer. rHuPH20
69  2021 Dopamine receptors in the anterior cingulate cortex implicate in nicotine enhanced morphine analgesia. ACC, i.p
70  2021 Dose-dependent inactivation of airway tryptase with a novel dissociating anti-tryptase antibody (MTPS9579A) in healthy participants: A randomized trial. AUC, i.v, PDs, PKs
71  2021 E-selectin inhibitor is superior to low-molecular-weight heparin for the treatment of experimental venous thrombosis. LMWH
72  2021 Early use of canakinumab to prevent mechanical ventilation in select COVID-19 patients: A retrospective, observational analysis. COVID-19, IL, SOC
73  2021 Effect of Foeniculum Vulgare Aqueous and Alcoholic Seed Extract against Zoonotic Cutaneous Leishmaniasis. ---
74  2021 Effect of Meperidine on Equine Blood Histamine, Tryptase, and Immunoglobulin-E Concentrations. IgE, IM
75  2021 Effects of phosphodiesterase V inhibition alone and in combination with BNP on cardiovascular and renal response to volume load in human preclinical diastolic dysfunction. BNP, cGMP, HFpEF, LAV, LVEF, PDD, PDEVI, RVSP, VL
76  2021 Efficacy and Safety of Inhaled Human Insulin (Exu hera) Compared to Subcutaneous Insulin in Children Ages 6 to 11 Years with Type 1 Diabetes Mellitus: Results of a 3-Month, Randomized, Parallel Trial. EXU
77  2021 Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn's Disease. AE, CD, CI, PBO
78  2021 Efficacy and Safety of Peripherally Acting mu-Opioid Receptor Antagonist (PAMORAs) for the Management of Patients With Opioid-Induced Constipation: A Systematic Review. AEs, GI, OIC, PAMORAs, SBMs, TEAs
79  2021 Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the VISIBLE 2 Randomised Trial. anti-TNF, CD, CDAI
80  2021 Encapsulation of Recombinant MOMP in Extended-Releasing PLGA 85:15 Nanoparticles Confer Protective Immunity Against a Chlamydia muridarum Genital Challenge and Re-Challenge. i.n
81  2021 Establishment and characterization of murine models of asthma and subcutaneous immunotherapy for Humulus pollen allergy. AHR, i.p, Ig, SCIT, sIgG2a
82  2021 Evaluation of Lidocaine and Metabolite Pharmacokinetics in Hyaluronic Acid Injection. GX, LHA, MEGX, PK
83  2021 Evidence for functional G-coupled protein receptors 43 and 120 in subcutaneous and intramuscular adipose tissue of Angus crossbred steers. AMPKalpha, GPR43, IM, p-AMPKalpha
84  2021 Exploration of potential role of Rho GTPase in nicotine dependence-induced withdrawal syndrome in mice. DMSO, i.p
85  2021 Feasibility of chitosan-based nanoparticles approach for intranasal immunisation of live attenuated Japanese encephalitis vaccine. CM, CS, i.n, JE, JE-CV, NPs
86  2021 Fentanyl patch versus tramadol for the control of postoperative pain in canine ovariectomy and mastectomy. CMPS-SF, NAS
87  2021 First-in-human study demonstrating the safety and clinical efficacy of novel anti-IL-17A monoclonal antibody CJM112 in moderate to severe plaque psoriasis. PASI
88  2021 First-in-human study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of ALPN-101, a dual CD28/ICOS antagonist, in healthy adult subjects. CD28, ICOS, ICOSL, PD, PK, vIgD
89  2021 Flexible care in breast cancer. BC, BELIS, HCPs
90  2021 Foslevodopa/Foscarbidopa Is Well Tolerated and Maintains Stable Levodopa and Carbidopa Exposure Following Subcutaneous Infusion. APD, CD, LD, PK
91  2021 Harms and Benefits of Subcutaneous Hydration in Older Patients: Systematic Review and Meta-Analysis. CI, RR, s-osmolality
92  2021 Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From An Efficacy and Safety Study of Vedolizumab Intravenous Compared to Adalimumab Subcutaneous in Participants With Ulcerative Colitis (VARSITY). CI, RHI, TNF
93  2021 Ideal body position for epinephrine autoinjector administration. BMI, EAI, IM, SCTD
94  2021 Identification and characterization of the adipogenesis in intramuscular and subcutaneous adipocytes of the goose (Anser cygnoides). FABP4, IM, LPL
95  2021 IL-10-Dependent Amelioration of Chronic Inflammatory Disease by Microdose Subcutaneous Delivery of a Prototypic Immunoregulatory Small Molecule. CID, EAE, IL, REMID
96  2021 Immune response differs between intralymphatic or subcutaneous administration of GAD-alum in individuals with recent onset type 1 diabetes. T1D
97  2021 Immunosuppressive effect of PLGA-FK506-NPs in treatment of acute cardiac rejection via topical subcutaneous injection. HT, i.g, LNs, MST
98  2021 Impact of baseline clinical asthma characteristics on the response to mepolizumab: a post hoc meta-analysis of two Phase III trials. ACQ, FEV1, SGRQ
99  2021 Impact of Initial eGlycemic Management System Dosing Strategy on Time to Target Blood Glucose Range. BG, GM, LOS
100  2021 Impact of injection sites on clinical pharmacokinetics of subcutaneously administered peptides and proteins. PK